The Diagnosis That Widens

A Danish study described by the Barcelona Institute for Global Health (ISGlobal) offers a useful complication. Children and adolescents receiving attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD) diagnoses have become more similar to the wider population on several measured characteristics. The labels persisted. The population receiving them changed.

That is not evidence that the conditions are imaginary, less severe, or being overdiagnosed. Nor does it establish that the underlying occurrence of either condition stayed constant. It means a rising diagnosis count cannot, by itself, tell the whole story of what has changed.

The finding is stranger—and more useful—than a contest between “there are more cases” and “we are just noticing them.” It asks us to examine the people inside the count.

What changed in Denmark

The study, led by ISGlobal and Aarhus University and published in JAMA Psychiatry, examined information from more than 2.1 million Danish children and adolescents. According to the institutional account carried by ScienceDaily on September 24, researchers compared more than 71,000 young people diagnosed with ADHD or ASD between 2012 and 2022 with more than 713,000 who had received neither diagnosis.

Those numbers describe different levels of the research: the large population supplying information and the groups used for comparison. They should not be casually divided into a national prevalence estimate.

The researchers examined characteristics previously associated with these diagnoses: premature birth, low birth weight, lower parental education or household income, parental psychiatric history, and greater use of healthcare before diagnosis. Young people receiving diagnoses remained more likely to have many of those characteristics. But the differences narrowed over the study period.

The release gives low birth weight as an example. It describes children born at a low birth weight as 54 percent more likely than children born at a normal weight to receive an ADHD or ASD diagnosis at the beginning of the period; by the end, that difference was 17 percent. These are relative comparisons as reported in the release—not claims that 54 percent or 17 percent of those children received a diagnosis.

Comparable declines appeared in associations involving premature birth and several measures of socioeconomic disadvantage, the account says. The finding concerns the changing strength of associations with recorded diagnosis. It is not an experiment demonstrating that the biological consequences of premature birth changed.

The full publisher paper was inaccessible during checking. This article therefore relies on the retrieved institutional account for the study's results, not an independent examination of its detailed statistical methods. The release often discusses ADHD and ASD together; its combined descriptions should not be mistaken for identical findings for each condition separately.

Similar in which ways?

“More like the general population” is a phrase with enough room inside it for several bad interpretations to move in.

Here it refers to measured characteristics such as birth history and socioeconomic circumstances. It does not mean that researchers found the same symptoms, experiences, or support needs in everyone. Similarity on parental income is not a measure of how someone experiences a classroom. Birth weight is not a daily functioning score.

The distinction matters because the phrase can otherwise become a shortcut to a conclusion the authors explicitly reject: that newer diagnoses must be milder, less legitimate versions of older ones.

As senior author Oleguer Plana-Ripoll says in the release, the findings do not show overdiagnosis or reduced severity. They show that the population receiving diagnoses changed. Those are different propositions, however efficiently a headline might try to make them roommates.

A historical profile also is not an entrance requirement. A characteristic being more common among diagnosed people does not make it necessary for diagnosis. Nothing in this report licenses judging an individual's assessment by whether their family income or birth history resembles an older statistical average.

The study's important shift is in perspective: instead of treating the diagnosed population as a fixed group whose size alone changes, it examines how that group's composition changes too.

A diagnosis has a route

Separate clinical guidance helps explain why a diagnosis count is not a direct reading from a biological meter.

The US Centers for Disease Control and Prevention describes ADHD diagnosis as a process with several steps, not a single test. Its guidance notes that sleep disorders, anxiety, depression and certain learning disabilities can produce similar symptoms. For children, clinicians gather information about behavior in different settings, including home and school, and consider alternative or co-occurring conditions.

Autism has its own diagnostic process. The CDC says clinicians examine developmental history and behavior; there is no medical test such as a blood test that supplies the diagnosis. Its autism guidance distinguishes developmental monitoring, screening and formal evaluation. A brief screening tool can identify a reason to investigate, but it does not itself establish a diagnosis.

These US pages do not document how Danish practice changed between 2012 and 2022. They supply clinical context, not a causal explanation for the Danish findings. They also make clear why ADHD and autism should not be collapsed into one interchangeable category merely because one study investigates both.

A recorded diagnosis follows recognition, assessment and clinical judgment. Asking how those processes affect the recorded population does not undermine the reality of the condition. It is a way to understand what the record contains.

The absurdity is expecting a number produced through human institutions to arrive free of institutional context. Numbers are useful. They are not born with their own interpretation attached.

Several explanations, no allocated shares

The study's authors identify several possible contributors to the changing profile. Awareness may have increased. Healthcare and education systems may be identifying cases more effectively. Access to evaluation may have expanded. The point at which neurodevelopmental characteristics are considered clinically impairing may also have changed.

The research, as described in the release, cannot determine how much each possibility contributed.

That limitation is not a decorative caveat to place at the end after announcing a winner. It governs what can be said at the beginning. “Better recognition explains the increase” would overstate the evidence. So would “standards have simply slipped.” The study does not allocate the change among those competing accounts.

It also does not rule out changes in the underlying occurrence of the conditions. A changing diagnostic population and a changing underlying population are not mutually exclusive. The question is how much of each process is present, and this account cannot settle it.

Nor should Denmark quietly become shorthand for everywhere. Plana-Ripoll calls for research in other countries to test whether the findings replicate. A large sample improves the opportunity to study a particular population; it does not abolish geography, health systems or differences in practice.

The useful conclusion is narrower than a universal explanation and stronger than a shrug: who receives a diagnosis has changed in ways that matter when interpreting trends.

When an improving average changes its meaning

There is another consequence, less likely to dominate the headline but important for evaluating care.

The researchers suggest that some apparent improvements in outcomes among people with ADHD or ASD could partly reflect changes in the population receiving diagnoses, rather than an improvement in the prognosis of the conditions themselves.

Consider a hypothetical comparison—not a result reported by this study. A service measures an average outcome in one year's diagnosed group, then repeats the exercise a decade later. If the later group differs in circumstances relevant to that outcome, the average can change even without a corresponding improvement for otherwise comparable individuals.

That possibility does not prove that treatment or support failed. It means the average alone cannot assign credit. Researchers need to account for who is being compared before turning a trend into a verdict on an intervention.

The same caution works in the other direction. A population facing greater difficulties could obscure benefits that a simple before-and-after average misses. Composition is not a trick that only spoils good news; it is part of what gives a comparison meaning.

For readers, the practical question is wonderfully unglamorous: are these sufficiently comparable groups? It will rarely win a shouting match. It can prevent one from being mistaken for an explanation.

Plan for people, not a frozen profile

The release points toward implications for healthcare, education and social services. It does not provide a tested service redesign or calculate how resources should be distributed. Those choices require evidence about present needs, not just a chart of changing associations.

Still, the policy question follows naturally. If the population receiving diagnoses changes, why assume that yesterday's picture of that population remains a sufficient guide to tomorrow's support?

The answer is not to replace one stereotype with a newer, statistically fashionable one. It is to assess what people actually need. Broader resemblance to the general population on selected background characteristics is no justification for treating support as unnecessary.

This is where the coherenceist lens belongs: not as a claim that science has proved an ethical doctrine, but as a choice about what to do with better knowledge. Widen the circle without flattening the people inside it. Let the affected people help identify what an institution's categories fail to capture.

A system can keep its numbers reassuringly tidy by refusing to reconsider its picture of who belongs. That is order, not necessarily good care. Equally, expanding recognition is not sufficient if it leaves people with a name for their difficulties and no useful response.

The Danish findings do not tell us who merits help, and they should not be used to adjudicate an individual's diagnosis. They tell us to be more careful about reading population statistics as though the people behind them never change.

There is room here for both scientific restraint and human seriousness. Keep investigating why the numbers move. Keep distinguishing ADHD from autism, associations from causes, and recognition from prevalence. Meanwhile, do not make someone's need for understanding depend on winning a national argument about a graph.

The count can become more complicated without the obligation becoming less clear. Behind every expanding category are particular people. The useful destination is not a perfectly defended label. It is a better response to the person who has received it.